Culture

Militarization negatively influences green growth

image: Land vehicles, aircraft, and sea-vessels consume a gargantuan amount of fossil fuels.

Image: 
UrFU / Ilya Safarov.

Military expenditures are highly counterproductive to green economic growth- documented by a recent study conducted by UrFU economist collaboration with an international research team. Sustainable economic development or green growth requires cleaner energy and green technology that can mitigate the negative externalities (e.g., carbon emission) of economic growth. The study utilized various macroeconomic indicators for 21 OECD countries over the year 1980-2016. This empirical study focusing on the dynamic impact of innovation, militarization and renewable energy on the green economy is published in the journal "Environmental Science and Pollution Research".

On the one hand, the military-industry (land vehicles, aircraft, and sea-vessels) consume a gargantuan amount of fossil fuels. About 75% of the global non-renewable energy consumption (coal, gas, oil) is by military actions, economists claim. According to the BP report (without division by sectors), the five main consumers of oil, gas, coal in 2019 were China (120.64 EJ), the United States (78.81 EJ), India (31.01 EJ), Russia (26.2 EJ), and Japan (16.33 EJ).

On the other hand, militarization is one of the main sources of air and environmental pollution.

"Although there is a discrepancy in the environmental damages across the nations, the opulent countries invariably resume causing a challenge to the global ecosystem compared to the impoverishment of counterparts. For example, the Pentagon is the glaring example of a paramount consumer of non-renewable resources. The US maintains hundreds of military bases in sixty countries exclusively. Accordingly, recent armed forces' equipment consistently becomes extra capital, more resource-intensive, and waste-generative as they have a substantial dependency on fossil fuels. In the act of assessing, supporting, and maintaining an arsenal of weapons, a substantial amount of toxic substances is released which is known to cause harm to the land and water adjacent to the military bases and the surrounding communities," - says Sohag Kazi, co-author, senior researcher at the Department of Econometrics and Statistics, Ural Federal University.

Economists are not calling for abandoning militarization. Their suggestion is to not increase the annual funding for the military-industrial complex and to use renewable energy sources for military needs. The researches argue that switching from non-renewable energy to renewable energy in the production process would not significantly affect the output but would reduce carbon emissions.

"It is highly unlikely that governments would reduce the budget allocated for the defense purchases in developed countries for various reasons. However, we have a cautionary remark regarding the operation and maintenance of the military expenditures on green growth. It is recommended that developed countries curtail their military expenditures and non-renewable energy usage, and instead conduct their military operations more cautiously, certainly by using of renewable energy technology, which should help to contribute to a better world," - says Sohag Kazi.

The study was conducted with participation of economists from Ural Federal University (Russia), University of Western Australia (Australia), Drexel University (USA), University of Economics (Vietnam), Universiti Teknologi MARA (Malaysia).

Military expenditures combine all current and capital expenditures spent on the militia, together with pacifist forces and defense establishments. It also includes government bureaus involved in defense projects, paramilitary forces if they are trained and provided for armed forces operations, and military space activities.

Credit: 
Ural Federal University

Visa costs higher for people from poor countries

image: Map of the world showing average number of days that someone has to work to be able to afford a tourist visa

Image: 
Global Visa Cost Dataset

How much do people have to pay for a travel permit to another country? A research team from Göttingen, Paris, Pisa and Florence has investigated the costs around the world. What they found revealed a picture of great inequality. People from poorer countries often pay many times what Europeans would pay. The results have been published in the journal Political Geography.

Dr Emanuel Deutschmann from the Institute of Sociology at the University of Göttingen, together with Professor Ettore Recchi, Dr Lorenzo Gabrielli and Nodira Kholmatova (from Sciences Po Paris, CNR-ISTI Pisa and EUI Florence respectively) compiled a new dataset on visa costs for travel between countries worldwide. The analysis shows that on average people from North Africa and South Asia pay more than three times as much for tourist visas (at just under 60 US dollars), as people from Western Europe (at around 18 US dollars).

The inequality becomes even greater when the differences in wealth between countries are taken into account. While Europeans usually only have to work for a fraction of a day to be able to afford a travel permit, in some African and Asian countries the visa costs are equivalent to several weeks or even months of the average income.

"Our dataset provides information about a dimension of global inequality that has, so far, received little attention," says Deutschmann. "While Article 13 of the Universal Declaration of Human Rights states that every person has the right to move freely and to leave any country, including their own, in reality there are barriers at many different levels which can obstruct global mobility, depending on where you come from. And our data clearly shows that these barriers include visa costs."

Credit: 
University of Göttingen

Keeping it cool: New approach to thermal protection in outdoor wearable electronics

image: Wearable devices and biosensors for outdoor use require innovative designs and novel materials capable of keeping down their temperature, even in sunlight

Image: 
Ketut Subiyanto at Pexels

Wearable electronic devices like fitness trackers and biosensors, are very promising for healthcare applications and research. They can be used to measure relevant biosignals in real-time and send gathered data wirelessly, opening up new ways to study how our bodies react to different types of activities and exercise. However, most body-worn devices face a common enemy: heat.

Heat can accumulate in wearable devices owing to various reasons. Operation in close contact with the user's skin is one of them; this heat is said to come from internal sources. Conversely, when a device is worn outdoors, sunlight acts as a massive external source of heat. These sources combined can easily raise the temperature of wearable devices to levels that not only are uncomfortable for the user, but also cause erroneous readings and measurements. Unfortunately, researchers have been unable to completely address this issue. Most available heat sinks and dissipators for wearable devices are based on thin metallic layers, which block electromagnetic signals and thus hinder wireless communications.

In a recent study published in Advanced Science, scientists from Korea and the US have developed an innovative solution to combat heat in wearable biosensors. Led by Professor Young Min Song from Gwangju Institute of Science and Technology (GIST), Korea, the team produced a nano-/micro-voids polymer (NMVP), a flexible and nonmetallic cooler made from two perforated polymers: polymethylmetacrylate and styrene-ethylene-butylene-styrene.

The resulting material has many attractive qualities. First, it has almost 100% reflectivity in the solar spectrum, meaning that it reflects nearly all sunlight. Second, it has high emissivity in the range of frequencies known as the atmospheric window. Thus, the material can easily radiate excess heat into the atmosphere, which helps cool it down. Finally, the good mechanical properties of the new polymer make it suitable for outdoor wearable devices.

To test the effectiveness of their innovation, the scientists built a patch-type tissue oximeter equipped with an NMVP-based cooler. Thanks to the superior performance of the cooler, their wearable biosensor could externally measure the concentration of oxygen in blood more accurately than conventional oximeters while also maintaining a much lower temperature. "Our approach is the first demonstration of successful thermal management in wearable devices considering both internal and external heat sources without blocking wireless communications," remarks Prof. Song.

The promising results of this study could pave the way for the widespread adoption of wearable devices and biosensors, which will become powerful tools in health monitoring and the training of athletes. With eyes set on the future, Prof. Song comments: "Our flexible strategy for radiative cooling will help bring about thermally protected skin-like electronics, which in turn will make human body monitoring unobtrusive and imperceptible."

The term "cool gadgets" is likely to get a whole new meaning in the future!

Credit: 
GIST (Gwangju Institute of Science and Technology)

Research shows how mutations in SARS-CoV-2 allow the virus to dodge immune defenses

The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity--such as individuals receiving immune-suppressive drugs for autoimmune diseases--can become chronically infected. As a result, their weakened immune defenses continue to attack the virus without being able to eradicate it fully.

This physiological tug-of-war between human host and pathogen offers a valuable opportunity to understand how SARS-CoV-2 can survive under immune pressure and adapt to it.

Now, a new study led by Harvard Medical School scientists offers a look into this interplay, shedding light on the ways in which compromised immunity may render SARS-CoV-2 fitter and capable of evading the immune system.

The research, published March 16 in Cell, shows that a mutated SARS-CoV-2 from a chronically infected immunocompromised patient is capable of evading both naturally occurring antibodies from COVID-19 survivors as well as lab-made antibodies now in clinical use for treatment of COVID-19.

The patient case was originally described Dec. 3, 2020, as a New England Journal of Medicine report by scientists at Brigham and Women's Hospital a few weeks before the U.K. and South African variants were first reported to the World Health Organization. Interestingly, the patient-derived virus contained a cluster of changes on its spike protein--the current target for vaccines and antibody-based treatments--and some of these changes were later detected in viral samples in the U.K. and South Africa, where they appear to have arisen independently, the researchers said.

The newly published study, which builds on the initial case report, shows something more alarming still. Some of the changes found in the patient-derived virus have not been identified yet in dominant viral variants circulating in the population at large. However, these changes have been already detected in databases of publicly available viral sequences. These mutations remain isolated, the authors of the report said, but they could be harbingers of viral mutants that may spread across the population.

The researchers emphasize that variants initially detected in the U.K. and South Africa remain vulnerable to currently approved mRNA vaccines, which target the entire spike protein rather than just portions of it. Nonetheless, the study results could also offer a preview into a future, in which current vaccines and treatments may gradually lose their effectiveness against next-wave mutations that render the virus impervious to immune pressures.

"Our experiments demonstrated that structural changes to the viral spike protein offer workarounds that allow the virus to escape antibody neutralization," said study senior author Jonathan Abraham, assistant professor of microbiology in the Blavatnik Institute at Harvard Medical School and an infectious disease specialist at Brigham and Women's Hospital. "The concern here is that an accumulation of changes to the spike protein over time could impact the long-term effectiveness of monoclonal antibody therapies and vaccines that target the spike protein."

Although the scenario remains hypothetical for now, Abraham said, it underscores the importance of two things. First, reducing the growth and spread of mutations by curbing the virus's spread both through infection-prevention measures and through widespread vaccination. Second, the need to design next-generation vaccines and therapies that target less mutable parts of the virus.

"How the spike responded to persistent immune pressure in one person over a five-month period can teach us how the virus will mutate if it continues to spread across the globe," added Abraham, who co-leads the COVID-19 therapeutics working group of the Massachusetts Consortium on Pathogen Readiness (MassCPR). "To help stop the virus from circulating, it's critical to make sure that vaccines are rolled out in an equitable way so that everyone in every country has a chance to get immunized."

A game of survival

Mutations are a normal part of a virus's life cycle. They occur when a virus makes copies of itself. Many of these mutations are inconsequential, others are harmful to the virus itself and yet others may become advantageous to the microbe, allowing it to propagate more easily from host to host. This latter change allows a variant to become more transmissible. If a change on a variant confers some type of evolutionary advantage to the virus, this variant can gradually outcompete others and become dominant.

In the early months of the pandemic, the assumption--and hope--was that SARS-CoV-2 would not change too fast because, unlike most RNA viruses, it has a "proofreading" protein whose job is to prevent too many changes to the viral genome. But last fall, Abraham and colleagues became intrigued by--and then alarmed about--a patient receiving immune-suppressive treatment for an autoimmune disorder who had been infected with SARS-CoV-2. The patient had developed a chronic infection. A genomic analysis of the patient's virus showed a cluster of eight mutations on the viral spike protein, which the virus uses to enter human cells and that is the target of current antibody treatments and vaccines. Specifically, the mutations had clustered on a segment of the spike known as the receptor-binding domain (RBD), the part that antibodies latch onto to prevent SARS-CoV-2 from entering human cells.

Abraham and colleagues knew the changes were a sign that the virus had developed workarounds to the patient's immune defenses. But would these mutations allow the virus to dodge the immune assault of antibodies that were not the patient's own?

To answer the question, Abraham and colleagues created lab-made, noninfectious replicas of the patient virus that mimicked the various structural changes that had accumulated in the span of five months.

In a series of experiments, the researchers exposed the dummy virus to both antibody-rich plasma from COVID-19 survivors and to pharmaceutically made antibodies now in clinical use. The virus dodged both naturally occurring and pharmaceutical-grade antibodies.

Experiments with a monoclonal antibody drug that contains two antibodies showed the virus was entirely resistant to one of the antibodies in the cocktail and somewhat, although not fully, impervious to the other. The second antibody was four-times less potent in neutralizing the mutated virus.

Not all eight mutations rendered the virus equally resistant to antibodies. Two particular mutations conferred the greatest resistance to both natural and lab-grown antibodies.

In a final experiment, the researchers created a super antibody by cobbling together proteins from naturally occurring antibodies that had evolved over time to become more attuned to and better at recognizing SARS-CoV-2 and capable of latching onto it more tightly. The process, known as antibody affinity maturation, is the principle behind vaccine booster shots used to fortify existing antibodies. One specific variant containing mutations that had occurred late in the course of the patient's infection was capable of withstanding even this super-potent antibody. But the super-potent antibody did manage to neutralize viral mutations detected at a different time in the course of the infection.

"This observation underscores two points: That the virus is smart enough to eventually evolve around even our most potent antibody therapies, but that we can also get ahead by 'cooking' new potent antibodies now, before new variants emerge," Abraham said

Getting ahead of the virus

Taken together the findings underscore the need to further understand human antibody responses to SARS-CoV-2 and to untangle the complex interplay between virus and human host, the researchers said. Doing so would allow scientist to anticipate changes in the virus and design countermeasures around these mutations before they become widespread.

In the short term, this speaks to the greater need to design antibody-based therapies and vaccines that directly target more stable, less mutable parts of the spike protein beyond its mutation-prone RBD region.

Long-term, this means that scientists should pivot toward developing therapies that go beyond antibody immunity and include also so-called cellular immunity, which is driven by T cells--a separate branch of the immune system that is independent of antibody-based immunity.

The most immediate implication, however, Abraham said, is to stay on top of emerging mutations through aggressive genomic surveillance. This means that instead of merely detecting whether SARS-CoV-2 is present in a patient sample, the tests should also analyze the viral genome and look for mutations. The technology to do so exists and is used in several countries as a way to monitor viral behavior and track changes to the virus across the population.

"In the United States, especially, the strategy has been to test and say whether a person is infected or not infected," Abraham said. "But there's a lot more information in that sample that can be obtained to help us track whether the virus is mutating. I am encouraged by the concerted efforts across the world to monitor sequences more aggressively--doing so is critical."

"It is important for us to stay ahead of this virus as it continues to evolve," said study first author Sarah Clark, member of the Abraham lab and a fourth-year student in the Ph.D. Program in Virology at Harvard University. "My hope is that our study provides insights that allow us to continue to do that."

Credit: 
Harvard Medical School

Certain mouthwashes might stop COVID-19 virus transmission

Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell.

The study, published in the journal Pathogens, found that Listerine and the prescription mouthwash Chlorhexidine disrupted the virus within seconds after being diluted to concentrations that would mimic actual use. Further studies are needed to test real-life efficacy in humans.

The study was conducted in a lab using concentrations of the mouthwash and the time it would take to contact tissues to replicate conditions found in the mouth, said Daniel H. Fine, the paper's senior author and chair of the school's Department of Oral Biology.

The study found two other mouthwashes showed promise in potentially providing some protection in preventing viral transmission: Betadine, which contains povidone iodine, and Peroxal, which contains hydrogen peroxide. However, only Listerine and Chlorhexidine disrupted the virus with little impact on skin cells inside the mouth that provide a protective barrier against the virus.

"Both Povidone iodine and Peroxal caused significant skin cell death in our studies, while both Listerine and Chlorhexidine had minimal skin cell killing at concentrations that simulated what would be found in daily use," said Fine.

The team studied the efficacy of mouthwash potential for preventing viral transmission to better understand how dental providers can be protected from aerosols exhaled by patients. "As dentists, we're right there in a patient's face. We wanted to know if there's something that might lower the viral load,'' said coauthor Eileen Hoskin, an assistant professor at Rutgers School of Dental Medicine.

Fine cautions the public against relying on mouthwash as a way to slow the spread until it is proven in clinical trials on humans.

"The ultimate goal would be to determine whether rinsing two or three times a day with an antiseptic agent with active anti-viral activity would have the potential to reduce the ability to transmit the disease. But this needs to be investigated in a real-world situation,'' he said.

Previous research has shown various types of antiseptic mouthwashes can disrupt the novel coronavirus and temporarily prevent transmission, but this was one of the first studies that examined antiseptic rinse concentrations, time of contact and the skin-cell killing properties that simulated oral conditions. The study was conducted by a team of dental school scientists and virologist at the Public Health Research Institute.

"Since the SARS CoV-2 virus responsible for COVID-19 enters primarily through the oral and nasal cavity, oral biologists should be included in these studies because they have an in-depth understanding of oral infectious diseases," said Fine.

Credit: 
Rutgers University

NUS researchers harness AI to identify cancer cells by their acidity

image: The novel technique of using AI to quickly analyse cells for cancer diagnosis was developed by an NUS research team led by Professor Lim Chwee Teck (left). With him are two team members - Dr Jokhun Doorgesh Sharma (centre) and Dr Yuri Belotti (right).

Image: 
National University of Singapore

Singapore, 17 March 2021 - Healthy and cancer cells can look similar under a microscope. One way of differentiating them is by examining the level of acidity, or pH level, inside the cells.

Tapping on this distinguishing characteristic, a research team from the National University of Singapore (NUS) has developed a technique that uses artificial intelligence (AI) to determine whether a single cell is healthy or cancerous by analysing its pH. Each cancer test can be completed in under 35 minutes, and single cells can be classified with an accuracy rate of more than 95 per cent.

The research, led by Professor Lim Chwee Teck, Director of the Institute for Health Innovation & Technology (iHealthtech) at NUS, was first published in the journal APL Bioengineering on 16 March 2021.

"The ability to analyse single cells is one of the holy grails of health innovation for precision medicine or personalised therapy. Our proof-of-concept study demonstrates the potential of our technique to be used as a fast, inexpensive and accurate tool for cancer diagnosis," said Prof Lim, who is also from the NUS Department of Biomedical Engineering.

Using AI for cancer detection

Current techniques for examining a single cell can induce toxic effects or even kill the cell. The approach developed by Prof Lim and his team, however, can distinguish between cells originating from normal and cancerous tissue, as well as among different types of cancer. Crucially, all of these can be achieved while keeping the cells alive.

The NUS team's method relies on applying bromothymol blue - a pH-sensitive dye that changes colour according to the level of acidity of a solution - onto living cells. Due to its intracellular activity, each type of cell displays its own 'fingerprint' which consists of its own unique combination of red, green, and blue (RGB) components when illuminated. Cancer cells have an altered pH compared to healthy cells, so they react differently to the dye, and this changes their RGB fingerprint.

Using a standard microscope equipped with a digital colour camera, the RGB components emitted from the dye inside the cells are captured. By using an AI-based algorithm they developed, the NUS researchers were able to quantitatively map the unique acidic fingerprints so that the cell types examined can be easily and accurately identified. Thousands of cells originating from various cancerous tissues can be imaged simultaneously, and single-cell features can be extracted and analysed. Compared to current standard methods of cancer cell imaging which require several hours, the process developed by the NUS team can be completed in less than 35 minutes.

"Unlike other cell analysis techniques, our approach uses simple, inexpensive equipment, and does not require lengthy preparation and sophisticated devices. Using AI, we are able to screen cells faster and accurately. Furthermore, we can monitor and analyse living cells without causing any toxicity to the cells or the need to kill them. This would allow for further downstream analysis that may require live cells," explained Prof Lim.

Opening the door for faster detection

As their technique is simple, low cost, fast and high-throughput, the research team is planning to develop a real-time version of this technique where cancer cells can be automatically recognised, and promptly separated for further downstream molecular analysis, such as genetic sequencing, to determine any possible drug treatable mutation.

"We are also exploring the possibility of performing the real-time analysis on circulating cancer cells suspended in blood," shared Prof Lim. "One potential application for this would be in liquid biopsy where tumour cells that escaped from a primary tumour can be isolated in a minimally-invasive fashion from bodily fluids such as blood."

In addition, the group is looking forward to advancing their concept to detect different stages of malignancies from the cells tested.

Credit: 
National University of Singapore

Trouble for honeyeaters that sing the wrong song

image: Regent honeyeater

Image: 
David Stowe

The critically endangered regent honeyeater is losing its "song culture" due to the bird's rapidly declining population, according to new research from The Australian National University (ANU).

Just like humans learning to speak, many birds learn to sing by associating with older birds of the same species. They risk losing this skill if adults become too rare. And if they don't learn to sing a sexy enough song, their chances of mating are reduced.

"If endangered birds are unable to learn how to sing correctly, it seriously impacts their ability to communicate," lead author Dr Ross Crates said.

"It could also be exacerbating the honeyeater's population decline, because we know a sexy song increases the odds of reproduction in songbirds. Females will avoid males that sing unusual songs."

The study found that in places where there were still reasonable numbers of regent honeyeaters, males sang rich and complex songs. Where the birds were rare, males sang simplified or "totally incorrect" songs.

"For example, 18 male regent honeyeaters - or around 12 per cent of the total population - were only able to copy the songs of other bird species," study co-author Dr Dejan Stojanovic said.

"This lack of ability to communicate with their own species is unprecedented in a wild animal. We can assume that regent honeyeaters are now so rare that some young males never find an older male teacher."

The study also showed regent honeyeaters born in captivity have totally different songs to wild birds.

The research team believe this could prove crucial when it comes to conservation.

"The unusual songs of captive-bred birds could reduce their attractiveness to wild birds when they are eventually released," Dr Crates said.

"So we've devised a new strategy to teach young captive regent honeyeaters to sing the same song as the wild birds by playing them audio recordings.

"Loss of song culture is a major warning sign the regent honeyeater is on the brink of extinction and we still have a lot to learn about how to help them."

Credit: 
Australian National University

UK variant spread rapidly in care homes in England

The UK variant of SARS-CoV-2 spread rapidly in care homes in England in November and December last year, broadly reflecting its spread in the general population, according to a study by UCL researchers.

The study, published as a letter in the New England Journal of Medicine, looked at positive PCR tests of care home staff and residents between October and December. It found that, among the samples it had access to, the proportion of infections caused by the new variant rose from 12% in the week beginning 23 November to 60% of positive cases just two weeks later, in the week beginning 7 December.

In the south east of England, where the variant was most dominant, the proportion increased from 55% to 80% over the same period. In London, where the variant spread fastest, the proportion increased from 20% to 66%.

The researchers said the timing of infections suggested the new variant may have been passed from staff to residents, with positive cases among older people occurring later.

Senior author Dr Laura Shallcross (UCL Institute of Health Informatics) said: "Our findings suggest the UK variant spread just as quickly in care homes as it did in the general population. This shows the importance of public health measures to reduce transmission in the country as a whole."

Lead author Dr Maria Krutikov (UCL Institute of Health Informatics) said: "Our results are consistent with national trends, suggesting that the UK variant was present in care homes from early on, although our sample did not fully represent all care homes in England. As we carried out this work in December, we were able to inform public health decisions at the time.

"To see how viruses like Covid-19 are changing and to respond quickly and appropriately, it is really important we have an advanced surveillance system, with gene sequencing that can identify new variants as early as possible."

For the study, researchers analysed 4,442 positive PCR samples from care home staff and residents in England. These were all the positive tests of staff and residents processed from October to December at the Lighthouse laboratory in Milton Keynes, one of the UK's biggest coronavirus testing labs. Staff in care homes are tested every week, while residents are tested monthly.

PCR tests for SARS-CoV-2 are designed to detect three parts of the virus - the S gene, N gene, and ORF1ab. The UK variant, known as B.1.1.7., has changes in its S gene, or spike gene, which mean the tests do not detect this particular target.

This means researchers were able to identify the proportion of infections caused by the new variant by looking at the samples in which the other two targets, the N gene and ORF1b, were detected, but not the S gene.

They also compared Ct values, which show how much of the virus is present, to check the samples did not miss the S gene because they were "weaker" positive tests, with less viral material.

Their analysis showed that in late November, the proportion of infections associated with B.1.1.7 increased sharply in several regions of England. In London, this was from 20% (week beginning 23 November) to 66% (week beginning 7 December). In the east of England, it rose from 35% to 64% over the same period, while in the south east the increase was from 55% to 80%. The data was predominantly drawn from London, the south east and east of England and the Midlands, with fewer positive test samples from the north of England and the south west.

Most samples were from people aged under 65, as staff are tested much more frequently than residents. However, among samples from those aged over 65, the proportion of infections caused by the new variant rose from 14% in the week beginning 23 November to 76% in the week beginning 7 December. (The number of total positive samples was low - just 21 and 157 respectively.)

The research was conducted as part of the Vivaldi study looking at Covid-19 infections in care homes. It received support and funding from the Department of Health and Social Care.

Credit: 
University College London

Lightning strikes played a vital role in life's origins on Earth

image: An illustration of early Earth, as it would have looked around 4 billion years ago

Image: 
Lucy Entwisle

Lightning strikes were just as important as meteorites in creating the perfect conditions for life to emerge on Earth, geologists say.

Minerals delivered to Earth in meteorites more than 4 billion years ago have long been advocated as key ingredients for the development of life on our planet.

Scientists believed minimal amounts of these minerals were also brought to early Earth through billions of lightning strikes.

But now researchers from the University of Leeds have established that lightning strikes were just as significant as meteorites in performing this essential function and allowing life to manifest.

They say this shows that life could develop on Earth-like planets through the same mechanism at any time if atmospheric conditions are right. The research was led by Benjamin Hess during his undergraduate studies at the University of Leeds in the School of Earth and Environment.

Mr Hess and his mentors were studying an exceptionally large and pristine sample of fulgurite, - a rock created when lightning strikes the ground. The sample was formed when lightning struck a property in Glen Ellyn, Illinois, USA, in 2016, and donated to the geology department at Wheaton College nearby.

The Leeds researchers were initially interested in how fulgurite is formed but were fascinated to discover in the Glen Ellyn sample a large amount of a highly unusual phosphorous mineral called schreibersite.

Phosphorus is essential to life and plays a key role in all life processes from movement to growth and reproduction. The phosphorous present on early Earth's surface was contained in minerals that cannot dissolve in water, but schreibersite can.

Mr Hess, now a PhD student at Yale University, Connecticut, USA, said: "Many have suggested that life on Earth originated in shallow surface waters, following Darwin's famous "warm little pond" concept.

"Most models for how life may have formed on Earth's surface invoke meteorites which carry small amounts of schreibersite. Our work finds a relatively large amount of schreibersite in the studied fulgurite.

"Lightning strikes Earth frequently, implying that the phosphorus needed for the origin of life on Earth's surface does not rely solely on meteorite hits.

"Perhaps more importantly, this also means that the formation of life on other Earth-like planets remains possible long after meteorite impacts have become rare."

The team estimate that phosphorus minerals made by lightning strikes surpassed those from meteorites when the earth was around 3.5 billion years old, which is about the age of the earliest known micro-fossils, making lightning strikes significant in the emergence of life on the planet.

Furthermore, lightning strikes are far less destructive than meteor hits, meaning they were much less likely to interfere with the delicate evolutionary pathways in which life could develop.

The research, titled Lightning strikes as a major facilitator of prebiotic phosphorus reduction on early Earth, is published today (SEE EMBARGO) in Nature Communications.

The School of Earth and Environment funded the project under a scheme which enables undergraduate led research using high-end analytical facilities.

Dr Jason Harvey, Associate Professor of Geochemistry in Leeds' School of Earth and Environment, and Sandra Piazolo, Professor of Structural Geology and Tectonics in the School of Earth and Environment, mentored Mr Hess in the research project.

Dr Harvey said: "The early bombardment is a once in a solar system event. As planets reach their mass, the delivery of more phosphorus from meteors becomes negligible.

"Lightning, on the other hand, is not such a one-off event. If atmospheric conditions are favourable for the generation of lightning, elements essential to the formation of life can be delivered to the surface of a planet.

"This could mean that life could emerge on Earth-like planets at any point in time."

Professor Piazolo said: "Our exciting research opens the door to several future avenues of investigation, including search for and in-depth analysis of fresh fulgurite in Early Earth-like environment; in-depth analysis of the effect of flash heating on other minerals to recognize such features in the rock record, and further analysis of this exceptionally well-preserved fulgurite to identify the range of physical and chemical processes within.

"All these studies will help up to increase our understanding of the importance of fulgurite in changing the chemical environment of Earth through time."

Credit: 
University of Leeds

Practical nanozymes discovered to fight antimicrobial resistance

Nanozymes, a group of inorganic catalysis-efficient particles, have been proposed as promising antimicrobials against bacteria. They are efficient in killing bacteria, thanks to their production of reactive oxygen species (ROS).

Despite this advantage, nanozymes are generally toxic to both bacteria and mammalian cells, that is, they are also toxic to our own cells. This is mainly because of the intrinsic inability of ROS to distinguish bacteria from mammalian cells.

In a study published in Nature Communications, the research team led by XIONG Yujie and YANG Lihua from University of Science and Technology (USTC) of the Chinese Academy of Sciences (CAS) proposed a novel method to construct efficient-while-little-toxic nanozymes.

The researchers showed that nanozymes that generate surface-bound ROS selectively kill bacteria, while leaving the mammalian cells safe.

The selectivity is attributed to, on the one hand, the surface-bound nature of ROS generated by the nanozymes prepared by the team, and on the other hand, an unexpected antidote role of endocytosis, a cellular process that is common for mammalian cells while absent in bacteria.

Moreover, the researchers observed a few different nanozymes that generate surface-bound ROS but vary in chemical components and in physical structures, ending up finding that the anti-bacteria behaviors are similar. This fact brings to the conclusion that the advantage of selectively killing bacteria over mammalian cells is the general property of the nanozymes that produce surface-bound ROS.

Antimicrobial resistance (AMR) poses a threat to global health, which is the reason why our use of drugs against germs are gradually less effective.

Credit: 
University of Science and Technology of China

How bacterial traffic jams lead to antibiotic-resistant, multilayer biofilms

image: Swarming Bacillus subtilis cells form a multilayered biofilm in a dish when exposed to the antibiotic kanamycin (pictured here on the right-hand side of the dish)

Image: 
Grobas et al. (CC BY 4.0)

The bacterial equivalent of a traffic jam causes multilayered biofilms to form in the presence of antibiotics, shows a study published today in eLife.

The study reveals how the collective behaviour of bacterial colonies may contribute to the emergence of antibiotic resistance. These insights could pave the way to new approaches for treating bacterial infections that help thwart the emergence of resistance.

Bacteria can acquire resistance to antibiotics through genetic mutations. But they can also defend themselves via collective behaviours such as joining together in a biofilm - a thin, slimy film made up of many bacteria that is less susceptible to antibiotics. Swarms of bacteria can also undergo a phenomenon similar to human traffic jams called 'motility-induced phase separation', in which they slow down when there are large numbers of bacteria crammed together.

"In our study, we wanted to see whether swarming bacteria can use physical interactions such as motility-induced phase separation to overcome certain stresses including exposure to antibiotics," says first author Iago Grobas, a PhD student at Warwick Medical School, University of Warwick, UK.

In their study, Grobas and colleagues exposed a colony of a common environmental bacteria called Bacillus subtilis to an antibiotic called kanamycin in a dish in the laboratory. They recorded a time-lapse video of the bacteria's behaviour and found that they formed biofilms in the presence of the drug.

Specifically, the team showed that the biofilm forms because bacteria begin to group together a distance away from the antibiotic, giving way to multiple layers of swarming bacteria.

"The layers build up through a physical mechanism whereby groups of cells moving together collide with each other," Grobas explains. "The collision generates enough stress to pile up the cells, which then move slower, attracting more cells through a mechanism similar to motility-induced phase separation. These multiple layers then lead to biofilm formation."

Next, the team tested a strategy to stop this formation and thereby prevent antibiotic resistance from occurring in this way. They found that splitting a single dose in two steps without changing the total amount of antibiotics strongly reduced the emergence of a biofilm.

The authors say further research is now needed to determine if bacteria that are harmful to humans use similar behaviours to survive antibiotic exposure. If they do, then future treatments should take these behaviours into account in order to reduce antibiotic resistance.

"Our discoveries question the way we use antibiotics and show that increasing the dosage is not always the best way to stop biofilm development," says co-senior author Munehiro Asally, Associate Professor at the School of Life Sciences, University of Warwick. "The timing of the bacteria's exposure to drugs is also important."

"These insights could lead us to rethink the way antibiotics are administered to patients during some infections," concludes co-senior author Marco Polin, Associate Professor at the Department of Physics, University of Warwick, and a researcher at the Mediterranean Institute for Advanced Studies (IMEDEA), Mallorca.

Credit: 
eLife

Combination therapy may provide significant protection against lethal influenza

image: These findings provide important clues regarding the inflammatory cellular signature at different time intervals during severe influenza infection. Temporal dynamics in hematoxylin and eosin-stained lung sections or modified Geimsa-stained bronchoalveolar lavage cells from control and lethal influenza-challenged mice were evaluated at 1, 3, 5, 6, and 8 dpi. Initial epithelial cytopathic effects were prominently seen at 1 dpi (open arrow), which spread to alveoli and were followed by the severe inflammatory phase (3-5 dpi). By 6 dpi, significant vascular leakage and collapse of the alveoli became prominent, and animals died between 8-9 dpi with severe hemorrhagic exudates (hash) with abundant proteinaceous material in the alveolar spaces (asterisk). CON-Control; DPI-Days post infection; M-macrophage; L-lymphocyte; N-neutrophil, EP-epithelial cell. Representative image was selected from 5 mice per group.

Image: 
The American Journal of Pathology

Philadelphia, March 16, 2021 - A significant proportion of hospitalized patients with influenza develop complications of acute respiratory distress syndrome, driven by virus-induced cytopathic effects as well as exaggerated host immune response. Reporting in The American Journal of Pathology, published by Elsevier, investigators have found that treatment with an immune receptor blocker in combination with an antiviral agent markedly improves survival of mice infected with lethal influenza and reduces lung pathology in swine-influenza-infected piglets. Their research also provides insights into the optimal timing of treatment to prevent acute lung injury.

Previously, the investigators found that an excessive influx of neutrophils, infection fighting immune cells, and the networks they create to kill pathogens, known as neutrophil extracellular traps (NETs), contribute to acute lung injury in influenza infection. Formation of NETs by activated neutrophils occurs via a cell death mechanism called NETosis and the released NETs contain chromatin fibers that harbor toxic components.

A mouse model, commonly used in exploring influenza pathophysiology and drug therapies, was used in the current study. Because mice are not natural hosts for influenza, further validation in larger animals is necessary before testing in humans. Therefore, researchers also tested piglets infected with swine influenza virus. The animals were treated with a combination of a CXCR2 antagonist, SCH527123, together with an antiviral agent, oseltamivir.

The combination of SCH527123 and oseltamivir significantly improved survival in mice compared to either of the drugs administered alone. The combination therapy also reduced pulmonary pathology in piglets.

"Combination therapy reduces lung inflammation, alveolitis, and vascular pathology, indicating that aberrant neutrophil activation and release in NETs exacerbate pulmonary pathology in severe influenza," explains lead investigator Narasaraju Teluguakula, PhD, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA. "These findings support the evidence that antagonizing CXCR2 may alleviate lung pathology and may have significant synergistic effects with antiviral treatment to reduce influenza-associated morbidity and mortality."

It can be challenging to balance the suppression of excessive neutrophil influx without compromising the beneficial host immunity conferred by neutrophils. Therefore, the researchers examined the temporal dynamics of NETs release in correlation with pathological changes during the course of infection in mice. During the early inflammatory phase, three to five days post infection, significant neutrophil activation and NETs release with relatively few hemorrhagic lesions was observed. In the late hemorrhagic exudative phase, significant vascular injury with declining neutrophil activity was seen.

Dr. Teluguakula also emphasizes that these findings provide the first evidence to support the strategy of testing combination therapy in a large animal influenza model. "In view of the close similarities in pulmonary pathology and immune responses between swine and humans, pig-influenza pneumonia models can serve as a common platform in understanding pathophysiology and host-directed drug therapies in human influenza infections and may be useful in advancing the translational impact of drug treatment studies in human influenza infections."

Credit: 
Elsevier

New imaging technology could help predict heart attacks

image: A new technique known as intravascular laser speckle imaging could one day be used to detect coronary plaques that are likely to lead to a heart attack. The researchers developed a small diameter intravascular catheter that incorporates a small-diameter fiber bundle, polarizer and GRIN lens to image the reflected speckle patterns onto a CMOS sensor.

Image: 
Seemantini Nadkarni, Wellman Center for Photomedicine

WASHINGTON -- Researchers have developed a new intravascular imaging technique that could one day be used to detect coronary plaques that are likely to lead to a heart attack. Heart attacks are often triggered when an unstable plaque ruptures and then blocks a major artery that carries blood and oxygen to the heart.

"If unstable coronary plaques could be detected before they rupture, pharmacological or other treatments could be initiated early to prevent heart attacks and save lives," said research team leader Seemantini Nadkarni from the Wellman Center for Photomedicine at Massachusetts General Hospital. "Our new imaging technique represents a major step toward achieving this."

In The Optical Society (OSA) journal Biomedical Optics Express, the researchers report a preclinical demonstration of their new intravascular laser speckle imaging (ILSI) technique in a living animal model. They show, for the first time, that ILSI can identify the distinct mechanical features of plaques that are most likely to rupture under physiological conditions of cardiac motion, blood flow and breathing.

"Reducing mortality from heart attacks in the general population requires a comprehensive screening strategy to identify at-risk patients and detect high-risk vulnerable plaques while they can be treated," said Nadkarni. "By providing the unique capability to measure mechanical stability -- a critical metric in detecting unstable plaques -- ILSI is poised to provide a new approach for coronary assessment."

Capturing mechanical stability of plaques
Although intravascular technologies have been developed to evaluate microstructural features of unstable plaques, recent studies have shown that mechanical features, in addition to microstructural and compositional features, influence plaque rupture.

"Measurement of the plaque mechanical properties is crucial in identifying unstable plaques with a propensity for rupture and subsequent heart attack," said Nadkarni. "ILSI provides the unique capability to quantify an index of mechanical properties of coronary plaques, thus providing a direct assessment of mechanical stability."

To estimate mechanical properties, ILSI uses laser speckle patterns that are formed when laser light is scattered from tissue. When viewed with a high-speed camera, the speckles fluctuate in time due to the viscoelastic properties of the plaque. This allows the researchers to measure and discriminate the mechanical properties of unstable plaques, which tend to be rich in lipids.

"For this new study, we developed a small diameter intravascular catheter that incorporates an optical fiber that delivers light to the coronary artery wall," said Nadkarni. "We also used a small-diameter fiber bundle, polarizer and GRIN lens to image the reflected speckle patterns onto a CMOS sensor."

For preclinical testing, the researchers evaluated the ability of their ILSI instrument to detect unstable plaques in a human coronary to swine xenograft model. This model system uses human coronary arteries that are sutured onto the beating heart of an anesthetized living pig. They assessed the mechanical properties of plaque inside the arteries by calculating the rate, or time constant, of fluctuations in the intensity of the speckle pattern and then compared their results with histopathological findings.

"The time constants in unstable plaques were significantly and distinctly lower than other stable plaques in the coronary wall," said Nadkarni. "These results demonstrated the exquisite diagnostic sensitivity and specificity of ILSI for detecting human lipid pool plaques that were most likely to rupture under physiological conditions."

The researchers say that the new technique could be easily integrated with other intracoronary technologies such as optical coherence tomography or intravascular ultrasound to combine the mechanical findings from ILSI with morphological information to improve the evaluation of plaque stability.

The researchers plan to continue to evaluate the capability of their ILSI instrument for rapid assessment of the coronary vasculature in live animals. Once these preclinical studies are complete, they will assess the safety of the catheter for use in humans and then begin the process of gaining regulatory approval for clinical use.

Credit: 
Optica

Patients value staff dedication most when evaluating substance use treatment facilities

Machine learning can be used to comb through online reviews of substance use treatment facilities to home in on qualities that are important to patients but remain hard to capture via formal means, such as surveys, researchers from the Perelman School of Medicine at the University of Pennsylvania show. The researchers found that professionalism and staff dedication to patients were two of the top qualities that could be attributed to either a negative or positive review of the facility. Findings from this study were published today in the Journal of General Internal Medicine.

"Searching for - and connecting with - therapy can be very difficult and confusing. Many individuals start their search online, where they are likely to see an online review accompanying other information about a treatment facility," said the study's lead author, Anish Agarwal, MD, a clinical innovation manager in the Penn Medicine Center for Digital Health and an assistant professor of Emergency Medicine. "These online reviews can provide commentary on what is driving positive, or negative, patient experiences throughout recovery, but they must be accurately identified. Through machine learning, we've shown that this is possible, and we hope such findings can be used to improve patient-centered addiction care."

Currently, there are no nationwide measures of quality to evaluate and compare facilities that treat substance use disorder. In the past, Agarwal - along with this study's co-author, Sharath Guntuku, PhD, a researcher in the Center for Digital Health and an assistant professor of Computer Science, and senior author Raina Merchant, MD, the director of the Center for Digital Health - analyzed reviews on Google and Yelp to see whether a national survey offered by the Substance Abuse and Mental Health Services Administration (SAMHSA) to inventory services being offered was also able to gauge patient satisfaction (it largely didn't). So the team set out to use a similar technique to gauge what drives positive or negative experiences with facilities through the unfiltered lens of Yelp.

"We felt that this would provide a great deal of insight into the patient experience," Guntuku said. "Tapping into user-generated reviews offers a way to understand their narrative."

To accomplish this, the researchers pulled reviews from SAMSHA-recognized facilities that had been reviewed at least five times. This amounted to more than 500 facilities across the United States. Text of the reviews were then run through a natural language processing algorithm powered by machine learning. Through this, topics were identified and collected from within the reviews. The researchers then were able to categorize them thematically.

Overall, the researchers classified 16 recurring themes in reviews. When it came to the positive reviews, the top themes were "long-term recovery," "dedicated staff," and "dedication to patients." The top three themes found in negative reviews were "professionalism," "phone communication," and "overall communication."

The fact that the top themes for both positive and negative reviews had to do with the conduct and commitment of facility staff does not come as a great surprise.

"Dedication and professionalism are critical to the recovery experience," Agarwal said. "Having trusted and approachable staff who care about individuals is the crux of all health care, but it is likely underscored in addiction."

Other top themes on the positive side were "group therapy experience" and "inpatient rehabilitation," while "wait times in facility" and "management" rounded out the top five most prevalent themes among negative reviews.

"We are still relatively early in this research, but we're getting a direct look into some core values that substance use treatment facilities could use to guide and improve their treatment," Merchant said. "This feedback is tremendously valuable, and we're showing that it can be distilled effectively into key themes through the use of machine learning."

Agarwal said he and the other researchers are hoping to explore more ways that patients, families, and their support networks think about substance use treatment and health care as a whole.

"In today's digital world, there is a robust and enormous amount of interconnectedness which we can harness to drive forward quality care and support health systems in learning from their patients," Agarwal said.

Credit: 
University of Pennsylvania School of Medicine

New study predicts changing Lyme disease habitat across the West Coast

FLAGSTAFF, Ariz. -- March 16, 2021 -- The findings of a recent analysis conducted by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that ecosystems suitable for harboring ticks that carry debilitating Lyme disease could be more widespread than previously thought in California, Oregon and Washington.

Bolstering the research were the efforts of an army of "citizen scientists" who collected and submitted 18,881 ticks over nearly three years through the Free Tick Testing Program created by the Bay Area Lyme Foundation, which funded the research, producing a wealth of data for scientists to analyze.

This new study builds on initial research led by the late Nate Nieto, Ph.D., at Northern Arizona University, and Daniel Salkeld, Ph.D., of Colorado State University.

This immense sample collection represented a multi-fold increase in the number of ticks that could be gathered by professional biologists conducting field surveys in far less time and at a fraction of the cost. This kind of citizen participation -- which in the future could include smart-phone apps and photography -- could become "a powerful tool" for tracking other animal- and insect-borne infectious diseases important for monitoring human and environmental health, according to study results published in the scientific journal PLOS ONE.

This study expands on previous work in California and is the first study to produce high resolution distributions of both actual and potential tick habitat in Oregon and Washington.

"This study is a great example of how citizen scientists can help -- whether tracking climate change, fires, habitat changes or species distribution shifts -- at a much finer scale than ever before," said Tanner Porter, Ph.D., a TGen Research Associate and lead author of the study.

Specifically, Dr. Porter said the findings of this study could help raise awareness among physicians across the West, and throughout the nation, that tick-borne diseases are possible throughout a wider expanse than ever thought before.

Lyme disease is caused by a bacteria, Borrelia burgdorferi (sensu lato), which is carried by ticks, and in this study specifically, the western black-legged tick known as Ixodes pacificus. These ticks also carry pathogens associated with relapsing fever and anaplasmosis, which like Lyme disease can cause fever, headache, chills and muscle aches. Some patients with Lyme disease may experience a rash that may look like a red oval or bull's-eye.

If not treated promptly, Lyme disease can progress to a debilitating stage, becoming difficult and sometimes impossible to cure. This may include inflammation of the heart and brain.

Lyme disease is the most common tickborne illness in the U.S., annually causing an estimated 500,000 infections, according to the CDC. However, even the most commonly-used diagnostic test for Lyme disease misses up to 70% of early stage cases. There is no treatment that works for all patients.

"We hope this study data encourages residents of California, Oregon and Washington to take precautions against ticks in the outdoors, and helps to ensure that local healthcare professionals will consider diagnoses of Lyme when patients present with symptoms," said Linda Giampa, Executive Director of the Bay Area Lyme Foundation.

Citizen scientists were encouraged to mail in ticks collected off individuals' bodies, pets and clothing. They noted the time and place where the ticks were discovered, and described activities involved, the surrounding environment, and in many cases specific GPS coordinates.

Field studies could take decades to produce the same amount of data, said Dr. Porter, adding, "this citizen science technique could allow for real-time distribution monitoring of ticks and other relevant species, an important consideration with emerging pathogens, changing land-use patterns, and climate change."

Credit: 
The Translational Genomics Research Institute